Kaplan-Meier analysis of patients with HR+/HER2- breast cancer showed that 10-year DFS differed significantly between patients with tChoi <15 and ≥15, with mean DFS times of 119.11 months and 115.09 months, respectively (log rank p = 0.017). This evidence concerns the gene ERBB2 and breast cancer.